11/21
08:00 am
calc
CalciMedica to Participate in the Piper Sandler 36th Annual Healthcare Conference
Low
Report
CalciMedica to Participate in the Piper Sandler 36th Annual Healthcare Conference
11/20
04:05 pm
calc
CalciMedica Announces Presentations at Upcoming Medical Meetings
Low
Report
CalciMedica Announces Presentations at Upcoming Medical Meetings
11/14
08:15 am
calc
CalciMedica, Inc. (NASDAQ: CALC) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $16.00 price target on the stock.
Low
Report
CalciMedica, Inc. (NASDAQ: CALC) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $16.00 price target on the stock.
11/13
07:00 am
calc
CalciMedica Reports Third Quarter 2024 Financial Results and Provides Clinical & Corporate Updates
Low
Report
CalciMedica Reports Third Quarter 2024 Financial Results and Provides Clinical & Corporate Updates
11/7
07:00 am
calc
CalciMedica Strengthens Leadership Team with Appointment of Stephen Bardin as Chief Financial Officer
Medium
Report
CalciMedica Strengthens Leadership Team with Appointment of Stephen Bardin as Chief Financial Officer
11/4
08:19 am
calc
CalciMedica, Inc. (NASDAQ: CALC) had its price target lowered by analysts at HC Wainwright from $20.00 to $16.00. They now have a "buy" rating on the stock.
Medium
Report
CalciMedica, Inc. (NASDAQ: CALC) had its price target lowered by analysts at HC Wainwright from $20.00 to $16.00. They now have a "buy" rating on the stock.
10/30
10:11 pm
calc
CalciMedica Announces Pricing of Public Offering of Common Stock
High
Report
CalciMedica Announces Pricing of Public Offering of Common Stock
10/30
04:50 pm
calc
CalciMedica Announces Proposed Public Offering of Common Stock
High
Report
CalciMedica Announces Proposed Public Offering of Common Stock
10/30
07:00 am
calc
CalciMedica to Present Late-Breaking Positive Data, Including a Win Ratio Analysis, from Phase 2b CARPO Trial of Auxora™ in Acute Pancreatitis (AP) at the American College of Gastroenterology (ACG) 2024 Annual Scientific Meeting
High
Report
CalciMedica to Present Late-Breaking Positive Data, Including a Win Ratio Analysis, from Phase 2b CARPO Trial of Auxora™ in Acute Pancreatitis (AP) at the American College of Gastroenterology (ACG) 2024 Annual Scientific Meeting
10/28
04:05 pm
calc
CalciMedica to Host a Call to Review Full Data Set, including a Win Ratio Analysis, from Phase 2b CARPO Trial of Auxora™ in Acute Pancreatitis (AP)
Low
Report
CalciMedica to Host a Call to Review Full Data Set, including a Win Ratio Analysis, from Phase 2b CARPO Trial of Auxora™ in Acute Pancreatitis (AP)
10/16
08:00 am
calc
CalciMedica Announces Upcoming Late-Breaker Plenary Presentation at the American College of Gastroenterology (ACG) 2024 Annual Scientific Meeting
Medium
Report
CalciMedica Announces Upcoming Late-Breaker Plenary Presentation at the American College of Gastroenterology (ACG) 2024 Annual Scientific Meeting
9/3
08:00 am
calc
CalciMedica to Present at the H.C. Wainwright 26th Annual Global Investment Conference
High
Report
CalciMedica to Present at the H.C. Wainwright 26th Annual Global Investment Conference